NEVVI Medicare utilization intelligence

← back

WASIL, TARUNMD NPI 1710949862 Clinician

Hematology-Oncology · NEW HYDE PARK, NY

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 45 years since medical school (class of 1981, self-reported to CMS)
Location NEW HYDE PARK, NY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 78 codes billed · 58,371 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20222026
NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC
2022–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2021-12

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
88185 Flow cytometry technique for dna or cell analysis, each additional marker
J0897 Injection, denosumab, 1 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J1100 Injection, dexamethasone sodium phosphate, 1 mg
83735 Magnesium level
83615 Lactate dehydrogenase (enzyme) level
84550 Uric acid level, blood
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
84100 Phosphate level
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
82784 Gammaglobulin (immune system protein) measurement
85044 Red blood count, manual test
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
83521 Measurement of immunoglobulin light chains
82607 Cyanocobalamin (vitamin b-12) level
96372 Injection of drug or substance under skin or into muscle
82378 Carcinoembryonic antigen (cea) protein level
82746 Folic acid level, serum
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
83010 Haptoglobin (serum protein) level
84165 Protein measurement, serum
86334 Immunologic analysis technique on serum (immunofixation)
96413 Administration of chemotherapy into vein, 1 hour or less
84443 Blood test, thyroid stimulating hormone (tsh)
84403 Testosterone (hormone) level, total
82232 Beta-2 microglobulin (protein) level
88184 Flow cytometry technique for dna or cell analysis, first marker
96375 Injection of additional new drug or substance into vein
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
84153 Psa (prostate specific antigen) measurement, total
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
96360 Infusion into a vein for hydration, 31-60 minutes
J1200 Injection, diphenhydramine hcl, up to 50 mg
86141 Measurement c-reactive protein for detection of infection or inflammation, high sensitivity
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96361 Infusion into a vein for hydration, each additional hour
96374 Injection of drug or substance into vein
J7050 Infusion, normal saline solution, 250 cc
82306 Vitamin d-3 level
82533 Cortisol (hormone) measurement, total
82668 Erythropoietin (protein) level
84439 Thyroxine (thyroid chemical), free
96417 Administration of additional new drug or substance into vein, 1 hour or less
86431 Rheumatoid factor level
83036 Hemoglobin a1c level
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
82248 Bilirubin level, direct
85610 Blood test, clotting time
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
86038 Screening test for autoimmune disorder
80074 Acute hepatitis panel
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
96415 Administration of chemotherapy into vein, each additional hour
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99195 Drawing of blood for a medical problem
81002 Urinalysis, manual test
87389 Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
81219 Gene analysis (calreticulin), common variants
81270 Gene analysis (janus kinase 2) variant
81279 Gene analysis (janus kinase 2) targeted sequence analysis
81338 Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants
83970 Parathormone (parathyroid hormone) level
G0452 Molecular pathology procedure; physician interpretation and report
80061 Blood test, lipids (cholesterol and triglycerides)

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.